SCHEMBL4762182

SCHEMBL4762182

CCOC(=O)N1CCN(Cc2nc(Cl)c3c4c(oc3n2)CCCC4)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 3/20 0.44
KCNH2 Q12809 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 2/20 0.41
ATM Q13315 1/20 0.40
ACACA Q13085 1/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
SMYD3 Q9H7B4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX15 P16050 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368664 0.66 KDM4E (0.37) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C19
SCHEMBL11093397 0.65 DRD2 (0.70) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2D6
SCHEMBL4764889 0.64 ACACA (0.37) ALDH1A1KDM4EHTTKMT2AACACA
SCHEMBL27625186 0.63 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2D6
SCHEMBL9819832 0.63 MEN1 (0.68) ALDH1A1KDM4ESMN1; SMN2KMT2AATM
SCHEMBL27883981 0.62 KDM4E (0.56) ALDH1A1KDM4ESMN1; SMN2HTTTSHR
SCHEMBL4466600 0.61 ALDH1A1 (0.59) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL1684895 0.61
SCHEMBL10985089 0.61 ALDH1A1 (0.72) ALDH1A1KDM4ESMN1; SMN2HTTKMT2A
SCHEMBL7475308 0.61 ALDH1A1 (0.70) ALDH1A1KDM4ESMN1; SMN2CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432715-B1 PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2008-03-19 EP disclosed
US-7312224-B2 Pyrimidine derivatives MERCK PATENT GMBH (DE) 2007-12-25 US disclosed
US-20040242595-A1 Pyrimidine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242595-A1 Pyrimidine derivatives TYMP, DPYD, TYMS ALDH1A1 671/4885KDM4E 2620/4885KCNH2 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.